The concept is supported by the increased susceptibility of IFN-γ-deficient mice to experimental TB [4–6] and severe mycobacterial infections in humans bearing mutations in IFN-γ/IFN-γ axis [7–9]. The gene discussed is IFNG; the disease is tuberculosis.